3005 Covid Vaccine deaths reported by CDC, Johnson & Johnson vaccine on pause with 1 death 1 woman in critical condition 6 cases of blood clots, “severe headache, abdominal pain, leg pain or shortness of breath”
“More than 6,000 healthy children in the U.S. and Canada will be enrolled in the Moderna Covid-19 Vaccine Study for which the benefits to society are nil and the risks unknown.”...Citizen Wells
“it is my sincere hope that this public letter might stimulate FDA, Pfizer and Moderna leaders to think critically and quickly about the immunological danger the COVID-19 vaccine might pose to those persons naturally infected by SARS-CoV-2 — most especially to those infected who are recently convalescent, asymptomatic carriers, the elderly and frail or those with significant cardiovascular risk factors.”...Dr. Hooman Noorchashm
“We are being lied to on a scale unimaginable by George Orwell.”…Citizen Wells
From the CDC.
“CDC and FDA have recommended a pause in the use of the Johnson & Johnson’s Janssen COVID-19 vaccine in the United States out of an abundance of caution, effective Tuesday, April 13. CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday, April 14, to address this issue. People who have received the J&J/Janssen COVID-19 vaccine within the past three weeks who develop severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider.”
“Over 189 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through April 12, 2021. During this time, VAERS received 3,005 reports of death (0.00158%) among people who received a COVID-19 vaccine.”
From the Defender.
“Federal agencies today said they will stop using the single-shot Johnson & Johnson (J&J) COVID vaccine at mass vaccination sites while they investigate the vaccine’s possible link to potentially dangerous blood clots. States and other providers also are expected to pause vaccinations.
In a joint statement from the Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA), the agencies said they are investigating six cases of blood clots in the U.S. All six occurred in women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination.
One woman died and a second woman in Nebraska was hospitalized and is in critical condition, The New York Times reported.
The CDC will convene a meeting of the Advisory Committee on Immunization Practices Wednesday to further review the cases and assess their potential significance. The FDA will review that analysis, according to the joint statement.
The agencies said that until “that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution.”
In addition to advising healthcare workers to report any adverse reactions to the Vaccine Adverse Event Reporting System, the agencies recommended people who have received the J&J vaccine and develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their healthcare provider.
Blood clots have also been linked to AstraZeneca’s COVID vaccine, which has not yet been approved in the U.S.”